Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6EUS

Crystal structure of the outer membrane channel DcaP of Acinetobacter baumannii

Summary for 6EUS
Entry DOI10.2210/pdb6eus/pdb
DescriptorDcaP-like protein (2 entities in total)
Functional Keywordsouter membrane protein, acinetobacter baumannii, membrane protein
Biological sourceAcinetobacter baumannii
Total number of polymer chains6
Total formula weight249151.19
Authors
Zahn, M.,van den Berg, B. (deposition date: 2017-10-31, release date: 2018-11-14, Last modification date: 2024-11-06)
Primary citationBhamidimarri, S.P.,Zahn, M.,Prajapati, J.D.,Schleberger, C.,Soderholm, S.,Hoover, J.,West, J.,Kleinekathofer, U.,Bumann, D.,Winterhalter, M.,van den Berg, B.
A Multidisciplinary Approach toward Identification of Antibiotic Scaffolds for Acinetobacter baumannii.
Structure, 27:268-280.e6, 2019
Cited by
PubMed Abstract: Research efforts to discover potential new antibiotics for Gram-negative bacteria suffer from high attrition rates due to the synergistic action of efflux systems and the limited permeability of the outer membrane (OM). One strategy to overcome the OM permeability barrier is to identify small molecules that are natural substrates for abundant OM channels and use such compounds as scaffolds for the design of efficiently permeating antibacterials. Here we present a multidisciplinary approach to identify such potential small-molecule scaffolds. Focusing on the pathogenic bacterium Acinetobacter baumannii, we use OM proteomics to identify DcaP as the most abundant channel during infection in rodents. The X-ray crystal structure of DcaP reveals a trimeric, porin-like structure and suggests that dicarboxylic acids are potential transport substrates. Electrophysiological experiments and all-atom molecular dynamics simulations confirm this notion and provide atomistic information on likely permeation pathways and energy barriers for several small molecules, including a clinically relevant β-lactamase inhibitor.
PubMed: 30554842
DOI: 10.1016/j.str.2018.10.021
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.2 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon